News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Week In Review: Biotech In Positive Territory For 2007


4/9/2007 3:08:27 PM

April 8, 2007 -- Biotech had a very positive week. Over the four sessions, the Centient Biotech 200™ rose 116 points to 3995, a 3% climb. That puts biotech back in the black for 2007 with a gain of 1.8% since the first of the year. Breadth was very solid, even when measured against a 3% rise in the index. Simcere, a Chinese maker of generic drugs for its home market, set terms for its IPO. Corcept led the list of biotech companies higher with a gain of 55% after it raised new cash; Bioveris also booked a 55% rise on a buyout offer; Dendreon continued to climb on the FDA recommendation for Provenge; Encysive received permission to market Thelin in Ireland, and Antigenics rose after Dendreon increased the prospects for cancer immunotherapies. More details...



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES